Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 371

1.

Cholecystokinin Downregulates Psoriatic Inflammation by Its Possible Self-Regulatory Effect on Epidermal Keratinocytes.

Funakoshi A, Tatsuno K, Shimauchi T, Fujiyama T, Ito T, Tokura Y.

J Immunol. 2019 May 1;202(9):2609-2615. doi: 10.4049/jimmunol.1801426. Epub 2019 Mar 22.

PMID:
30902899
2.

The Vitamin D3 analogue calcipotriol suppresses CpG-activated TLR9-MyD88 signalling in murine plasmacytoid dendritic cells.

Suzuki T, Sakabe J, Kamiya K, Funakoshi A, Tokura Y.

Clin Exp Dermatol. 2018 Jun;43(4):445-448. doi: 10.1111/ced.13397. Epub 2018 Feb 1.

PMID:
29392742
3.

Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study.

Hagiwara Y, Ohashi Y, Okusaka T, Ueno H, Ioka T, Boku N, Egawa S, Hatori T, Furuse J, Mizumoto K, Ohkawa S, Yamaguchi T, Yamao K, Funakoshi A, Cheng AL, Kihara K, Sato A, Tanaka M.

ESMO Open. 2017 Mar 15;2(1):e000151. doi: 10.1136/esmoopen-2016-000151. eCollection 2017.

4.

Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer.

Okusaka T, Miyakawa H, Fujii H, Nakamori S, Satoh T, Hamamoto Y, Ito T, Maguchi H, Matsumoto S, Ueno H, Ioka T, Boku N, Egawa S, Hatori T, Furuse J, Mizumoto K, Ohkawa S, Yamaguchi T, Yamao K, Funakoshi A, Chen JS, Cheng AL, Sato A, Ohashi Y, Tanaka M; GEST group.

J Cancer Res Clin Oncol. 2017 Jun;143(6):1053-1059. doi: 10.1007/s00432-017-2349-y. Epub 2017 Feb 16.

5.

Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol.

Suzuki T, Tatsuno K, Ito T, Sakabe JI, Funakoshi A, Tokura Y.

J Dermatol Sci. 2016 Oct;84(1):71-79. doi: 10.1016/j.jdermsci.2016.06.003. Epub 2016 Jun 3.

PMID:
27342039
6.

Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion.

Fujiyama T, Ito T, Umayahara T, Ikeya S, Tatsuno K, Funakoshi A, Hashizume H, Tokura Y.

J Allergy Clin Immunol. 2016 Aug;138(2):517-528.e5. doi: 10.1016/j.jaci.2016.03.048. Epub 2016 May 11.

PMID:
27315769
7.

[Various cancers related type 2 diabetes mellitus: Pancreatic cancer].

Funakoshi A.

Nihon Rinsho. 2016 Apr;74 Suppl 2:421-5. Japanese. No abstract available.

PMID:
27266128
8.

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer.

Ohkawa S, Okusaka T, Isayama H, Fukutomi A, Yamaguchi K, Ikeda M, Funakoshi A, Nagase M, Hamamoto Y, Nakamori S, Tsuchiya Y, Baba H, Ishii H, Omuro Y, Sho M, Matsumoto S, Yamada N, Yanagimoto H, Unno M, Ichikawa Y, Takahashi S, Watanabe G, Wakabayashi G, Egawa N, Tsuda M, Hosotani R, Hamada C, Hyodo I.

Br J Cancer. 2015 Apr 28;112(9):1428-34. doi: 10.1038/bjc.2015.103. Epub 2015 Apr 16.

9.

Cellular and subcellular localization of cholecystokinin (CCK)-1 receptors in the pancreas, gallbladder, and stomach of mice.

Konno K, Takahashi-Iwanaga H, Uchigashima M, Miyasaka K, Funakoshi A, Watanabe M, Iwanaga T.

Histochem Cell Biol. 2015 Mar;143(3):301-12. doi: 10.1007/s00418-014-1281-3. Epub 2014 Sep 24.

10.

Significant factors in family difficulties for fathers and mothers who use support services for children with hikikomori.

Funakoshi A, Miyamoto Y.

Psychiatry Clin Neurosci. 2015 Apr;69(4):210-9. doi: 10.1111/pcn.12230. Epub 2014 Sep 24.

11.

Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege.

Ito T, Suzuki T, Funakoshi A, Tokura Y.

Eur J Dermatol. 2014 Sep-Oct;24(5):631-3. doi: 10.1684/ejd.2014.2421. No abstract available.

PMID:
25115439
12.

The concept of "benefit finding" for people at different stages of recovery from mental illness; a Japanese study.

Chiba R, Miyamoto Y, Funakoshi A.

J Ment Health. 2014 Feb;23(1):20-4. doi: 10.3109/09638237.2013.841872.

PMID:
24484188
13.
14.

Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology.

Ito T, Bertolini M, Funakoshi A, Ito N, Takayama T, Biro T, Paus R, Tokura Y.

J Dermatol Sci. 2013 Dec;72(3):327-30. doi: 10.1016/j.jdermsci.2013.07.014. Epub 2013 Aug 8. No abstract available.

PMID:
24001790
15.

[Multiple pyogenic liver abscesses with the decline in neutrophil phagocytic function: a case report].

Okumura Y, Sugimoto R, Hisano T, Furukawa M, Fujiyama T, Taguchi K, Funakoshi A.

Nihon Shokakibyo Gakkai Zasshi. 2013 Aug;110(8):1487-94. Japanese.

PMID:
23912009
16.

Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study.

Ueno H, Ioka T, Ikeda M, Ohkawa S, Yanagimoto H, Boku N, Fukutomi A, Sugimori K, Baba H, Yamao K, Shimamura T, Sho M, Kitano M, Cheng AL, Mizumoto K, Chen JS, Furuse J, Funakoshi A, Hatori T, Yamaguchi T, Egawa S, Sato A, Ohashi Y, Okusaka T, Tanaka M.

J Clin Oncol. 2013 May 1;31(13):1640-8. doi: 10.1200/JCO.2012.43.3680. Epub 2013 Apr 1.

PMID:
23547081
17.

CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.

Ito T, Hashizume H, Shimauchi T, Funakoshi A, Ito N, Fukamizu H, Takigawa M, Tokura Y.

J Dermatol Sci. 2013 Feb;69(2):140-7. doi: 10.1016/j.jdermsci.2012.12.003. Epub 2012 Dec 26.

PMID:
23312578
18.

Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin.

Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka HU, Nishishita S, Sato C, Funakoshi A, Nishimori H, Uchida HA, Ogawa D, Makino H.

Diabetes. 2012 Apr;61(4):897-907. doi: 10.2337/db11-0402. Epub 2012 Feb 22.

19.

A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells.

Kawanami T, Takiguchi S, Ikeda N, Funakoshi A.

Oncol Rep. 2012 Mar;27(3):867-72. doi: 10.3892/or.2011.1597. Epub 2011 Dec 20.

PMID:
22200743
20.

Administration of ursodeoxycholate failed to prevent sludge and/or gallstone formation in cholecystokinin-1(A) receptor-deficient mice.

Nihei N, Sekime A, Miyasaka K, Kanai S, Takiguchi S, Funakoshi A.

Biomed Res. 2011 Dec;32(6):401-6.

21.

Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer.

Ueno H, Okusaka T, Furuse J, Yamao K, Funakoshi A, Boku N, Ohkawa S, Yokosuka O, Tanaka K, Moriyasu F, Nakamori S, Sato T.

Jpn J Clin Oncol. 2011 Aug;41(8):953-8. doi: 10.1093/jjco/hyr090. Epub 2011 Jun 29.

PMID:
21715364
22.

[A case of pancreatic well-differentiated neuroendocrine carcinoma surviving 8 years and 5 months with treatments for multiple liver tumors diagnosed as carcinoid tumor].

Okumura Y, Sugimoto R, Taguchi K, Lee L, Ueda K, Furukawa M, Funakoshi A.

Gan To Kagaku Ryoho. 2011 Jun;38(6):1043-7. Japanese.

PMID:
21677505
23.

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.

Kindler HL, Ioka T, Richel DJ, Bennouna J, Létourneau R, Okusaka T, Funakoshi A, Furuse J, Park YS, Ohkawa S, Springett GM, Wasan HS, Trask PC, Bycott P, Ricart AD, Kim S, Van Cutsem E.

Lancet Oncol. 2011 Mar;12(3):256-62. doi: 10.1016/S1470-2045(11)70004-3.

PMID:
21306953
24.

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer.

Okusaka T, Furuse J, Funakoshi A, Ioka T, Yamao K, Ohkawa S, Boku N, Komatsu Y, Nakamori S, Iguchi H, Ito T, Nakagawa K, Nakachi K.

Cancer Sci. 2011 Feb;102(2):425-31. doi: 10.1111/j.1349-7006.2010.01810.x. Epub 2010 Dec 22.

25.

Giardiasis in the pancreas accompanied by pancreatic cancer.

Furukawa M, Lee L, Ikegami T, Maeda T, Nishiyama K, Itaba S, Funakoshi A.

Pancreas. 2011 Jan;40(1):168-9. doi: 10.1097/MPA.0b013e3181f6a1b9. No abstract available.

PMID:
21160381
26.

Pancreatic hypertrophy in Ki-ras-induced actin-interacting protein gene knockout mice.

Miyasaka K, Fujimoto T, Kawanami T, Takiguchi S, Jimi A, Funakoshi A, Shirasawa S.

Pancreas. 2011 Jan;40(1):79-83. doi: 10.1097/MPA.0b013e3181f66c22.

PMID:
21160370
27.

[Survival benefits of chemotherapy for unresectable biliary tract cancer--a multicenter retrospective analysis].

Funakoshi A, Horiuchi H, Sakai T, Miyahara T, Muranaka T, Nakamura M, Mizumoto K, Ueki T, Taketomi A, Yamaguchi H, Sumii T, Ito T.

Gan To Kagaku Ryoho. 2010 Dec;37(13):2875-9. Japanese.

PMID:
21160263
28.

Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.

Yotsumoto F, Fukami T, Yagi H, Funakoshi A, Yoshizato T, Kuroki M, Miyamoto S.

Cancer Sci. 2010 Nov;101(11):2351-60. doi: 10.1111/j.1349-7006.2010.01671.x.

29.

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.

Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, Nagino M, Kondo S, Nagaoka S, Funai J, Koshiji M, Nambu Y, Furuse J, Miyazaki M, Nimura Y.

Br J Cancer. 2010 Aug 10;103(4):469-74. doi: 10.1038/sj.bjc.6605779. Epub 2010 Jul 13.

30.

Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer.

Miyasaka K, Hosoya H, Tanaka Y, Uegaki S, Kino K, Shimokata H, Kawanami T, Funakoshi A.

Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S120-6. doi: 10.1111/j.1447-0594.2010.00616.x.

PMID:
20590827
31.

Highest-occupied-molecular-orbital band dispersion of rubrene single crystals as observed by angle-resolved ultraviolet photoelectron spectroscopy.

Machida S, Nakayama Y, Duhm S, Xin Q, Funakoshi A, Ogawa N, Kera S, Ueno N, Ishii H.

Phys Rev Lett. 2010 Apr 16;104(15):156401. Epub 2010 Apr 14.

PMID:
20482000
32.

A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.

Furuse J, Okusaka T, Ohkawa S, Nagase M, Funakoshi A, Boku N, Yamao K, Yamaguchi T, Sato T.

Cancer Chemother Pharmacol. 2009 Dec;65(1):113-20. doi: 10.1007/s00280-009-1011-z. Epub 2009 Apr 29.

PMID:
19404641
33.

Gastric acid secretion in cholecystokinin-1 receptor, -2 receptor, and -1, -2 receptor gene knockout mice.

Kanai S, Hosoya H, Akimoto S, Ohta M, Matsui T, Takiguchi S, Funakoshi A, Miyasaka K.

J Physiol Sci. 2009 Jan;59(1):23-9. doi: 10.1007/s12576-008-0001-y. Epub 2008 Nov 30.

PMID:
19340558
34.

Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial.

Doi R, Imamura M, Hosotani R, Imaizumi T, Hatori T, Takasaki K, Funakoshi A, Wakasugi H, Asano T, Hishinuma S, Ogata Y, Sunamura M, Yamaguchi K, Tanaka M, Takao S, Aikou T, Hirata K, Maguchi H, Aiura K, Aoki T, Kakita A, Sasaki M, Ozaki M, Matsusue S, Higashide S, Noda H, Ikeda S, Maetani S, Yoshida S; Japan Pancreatic Cancer Study Group.

Surg Today. 2008;38(11):1021-8. doi: 10.1007/s00595-007-3745-8. Epub 2008 Oct 29.

PMID:
18958561
35.

Incidence of apoptosis in the pancreas of young and old rats.

Miyasaka K, Jimi A, Kanai S, Sato Y, Masuda M, Ohta M, Funakoshi A.

Arch Gerontol Geriatr. 1998 May-Jun;26(3):235-45.

PMID:
18653140
36.

[A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].

Fujimoto C, Maruyama Y, Niina Y, Fujimori N, Sumii T, Funakoshi A.

Gan To Kagaku Ryoho. 2008 Jun;35(6):1013-6. Japanese.

PMID:
18633236
37.

[Phase I/II study of combination chemotherapy with gemcitabine and UFT for advanced pancreatic cancer in a multi-center trial].

Sumii T, Funakoshi A, Mizumoto K, Tanaka M, Arita Y, Ito T, Yamaguchi H, Ueki T, Sakai T, Miyahara T, Muranaka T, Igarashi H, Shinozaki H, Eriguchi N.

Gan To Kagaku Ryoho. 2008 Apr;35(4):603-6. Japanese.

PMID:
18408428
38.

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study.

Furuse J, Okusaka T, Boku N, Ohkawa S, Sawaki A, Masumoto T, Funakoshi A.

Cancer Chemother Pharmacol. 2008 Oct;62(5):849-55. doi: 10.1007/s00280-007-0673-7. Epub 2008 Jan 23.

PMID:
18214482
39.

Is the OLETF rat a good model of central sensitization?

Miyasaka K, Funakoshi A.

J Pharmacol Sci. 2007 Dec;105(4):373. No abstract available.

40.

Cholecystokinin-A receptors regulate photic input pathways to the circadian clock.

Shimazoe T, Morita M, Ogiwara S, Kojiya T, Goto J, Kamakura M, Moriya T, Shinohara K, Takiguchi S, Kono A, Miyasaka K, Funakoshi A, Ikeda M.

FASEB J. 2008 May;22(5):1479-90. Epub 2007 Dec 11.

PMID:
18073333
41.

A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer.

Yonemoto N, Furuse J, Okusaka T, Yamao K, Funakoshi A, Ohkawa S, Boku N, Tanaka K, Nagase M, Saisho H, Sato T.

Jpn J Clin Oncol. 2007 Nov;37(11):843-51. Epub 2007 Oct 17.

PMID:
17942578
42.

Age-associated gallstone formation in male and female CCK-1(A) receptor-deficient mice.

Miyasaka K, Kanai S, Ohta M, Hosoya H, Sekime A, Akimoto S, Takiguchi S, Funakoshi A.

J Gastroenterol. 2007 Jun;42(6):493-6. Epub 2007 Jun 29.

PMID:
17671765
43.

Cholecystokinin 1A receptor polymorphisms.

Miyasaka K, Takiguchi S, Funakoshi A.

Curr Top Med Chem. 2007;7(12):1205-10. Review.

PMID:
17584142
44.

Susceptibility to obesity and gallbladder stasis produced by a protein- and fat-enriched diet in male mice compared with female mice.

Miyasaka K, Kanai S, Ohta M, Sekime A, Akimoto S, Takiguchi S, Funakoshi A.

Nutr Metab (Lond). 2007 Jun 5;4:14.

45.

A late phase II study of S-1 for metastatic pancreatic cancer.

Okusaka T, Funakoshi A, Furuse J, Boku N, Yamao K, Ohkawa S, Saito H.

Cancer Chemother Pharmacol. 2008 Apr;61(4):615-21. Epub 2007 May 23.

PMID:
17520253
46.

Managerial support of community mental health nurses.

Funakoshi A, Miyamoto Y, Kayama M.

J Adv Nurs. 2007 May;58(3):227-35.

PMID:
17474911
47.

Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan.

Ito T, Otsuki M, Itoi T, Shimosegawa T, Funakoshi A, Shiratori K, Naruse S, Kuroda Y; Research Committee of Intractable Diseases of the Pancreas.

J Gastroenterol. 2007 Apr;42(4):291-7. Epub 2007 Apr 26.

PMID:
17464458
48.

Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis.

Ito T, Kawabe K, Arita Y, Hisano T, Igarashi H, Funakoshi A, Sumii T, Yamanaka T, Takayanagi R.

Pancreas. 2007 Mar;34(2):254-9.

PMID:
17312466
49.

Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient mice.

Sakurai C, Ohta M, Kanai S, Uematsu H, Funakoshi A, Miyasaka K.

J Physiol Sci. 2006 Dec;56(6):441-7. Epub 2006 Dec 1.

PMID:
17134539
50.

[Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].

Funakoshi A, Senju T, Sumii T.

Gan To Kagaku Ryoho. 2006 Oct;33(10):1505-9. Japanese.

PMID:
17033248

Supplemental Content

Loading ...
Support Center